CJC-12955mg / Ipamorelin Blend5mg

10mg · Lyophilized Powder

$100.00 CAD

This pre-blended vial combines CJC-1295 (No DAC) with Ipamorelin in equal ratios for synergistic growth hormone secretagogue research. CJC-1295 (No DAC) activates the GHRH receptor to stimulate pulsatile GH release, while Ipamorelin independently activates the ghrelin receptor (GHSR) — triggering a rapid, selective GH pulse without raising cortisol, ACTH, or prolactin. Combined, the two peptides act on complementary receptor pathways to produce amplified GH release from a single once-daily injection.

Research Applications

•Synergistic GH release via dual GHRH and ghrelin receptor activation

•Pulsatile GH and IGF-1 elevation for body composition research

•Selective GH secretion without ACTH or cortisol elevation

•Body composition and lean mass research via combined GH signalling

•Recovery, sleep quality, and tissue repair research

•Simplified once-daily administration versus two-vial stack protocols

Blend Contents

CJC-1295 (No DAC) →Ipamorelin →

VIEW DOSING PROTOCOL →

Compare:Ipamorelin vs CJC-1295 →CJC-1295 No DAC vs DAC →HGH 191AA vs CJC-1295/Ipamorelin Blend →

1

SHARE

All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.